Diuré
Diuré, licence 80079434: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- NuWTR
- NPN or DIN-HM
- 80079434
- Status
- Inactive licence
- Licence date
- 14 August 2017
- Revision date
- 17 May 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Agathosma betulina Source : Feuille Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 400.0 mg | 100.0 mg | Not calculated |
| Juniperus communis Source : Fruit Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 400.0 mg | 100.0 mg | Not calculated |
| Arctostaphylos uva-ursi Source : Feuille Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 400.0 mg | 100.0 mg | Not calculated |
| Petroselinum crispum Source : Feuille | 75.0 mg | Not calculated |
| Apium graveolens Source : Graine(s) | 75.0 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 2.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditionally used in Herbal Medicine as a diuretic. Traditionally used in Herbal Medicine as a mild diuretic to help relieve symptoms associated with minor urinary tract infections, such as burning sensation and/or frequent urination. Used in Herbal Medicine to help relieve symptoms associated with minor urinary tract infections, such as burning sensation and/or frequent urination.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80079434
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.